Order your free sample
Try it for yourself! Order a free sample kit.
Wound infection can delay wound healing, significantly increasing costs and negatively impacting the patient’s quality of life. Early intervention using Cutimed Sorbact proactively to help break the wound infection continuum in the contamination and colonization phases, in wounds identified as high risk of infection.
Manage wound infection with Cutimed Sorbact
Cutimed Sorbact binds bacteria and fungi with a purely physical mode of action. The bound microbes are inhibited and removed from the wound, preventing them from releasing endotoxins, enhancing wound healing. Antimicrobial resistance is not expected.1
Learn more about early intervention and treatment of wound infections. Download the Wound Infection Pathway.
No release of active substances into the wound. Antimicrobial resistance is not expected. [1]
Use Cutimed Sorbact as an early intervention approach
Early intervention supports the use of proactive interventions for chronic wounds with a high risk of infection during the contamination and colonization phases. This can prevent a wound infection from developing and reducing the risk of having to treat wounds with antibiotics - supporting Antimicrobial Stewardship (AMS) strategies.
- Cutimed Sorbact is one of the first wound dressing choices for early intervention of contaminated wounds and the management of infection.2
- It is safe for the most delicate patients, from newborns to elderly.3, 4
- Versatile, safe and easy to use.3, 4
Effective in reducing bacterial burden
Studies show that Cutimed Sorbact is effective in reducing the bacterial burden in critically colonised or locally infected chronic leg ulcers.5
Respond to the rise of antimicrobial resistance with Cutimed Sorbact
The whole world has woken up to the challenge of antimicrobial resistance (AMR). Without effective tools for prevention and adequate treatment of infections, the number of people for whom treatment is failing will increase.
References
- Husmark J et al. Antimicrobial effects of bacterial binding to a dialkylcarbamoyl chloride-coated wound dressing: an in vitro study. J Wound Care. 2022:560-570. Read more
- Tong QJ et al. A systematic review and meta-analysis on the use of prophylactic topical antibiotics for the prevention of uncomplicated wound infections. Infect Drug Resist. 2018;11:417-25. Read more
- Ciprandi G et al. Meeting the challenges in pediatric wound care: Our 15-year experience with dialkylcarbamoyl chloride-coated dressing technology in acute and chronic wounds. Chronic Wound Care Management and Research. 2022;9:23-33. Read more
- Kammerlander G et al. An investigation of Cutimed Sorbact as an antimicrobial alternative in wound management. Wounds UK. 2008;4:10-18. Read more
- Mosti G et al. Comparative study of two antimicrobial dressings in infected leg ulcers: a pilot study. J Wound Care. 2015;24(3):121-127. Read more